Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Leukemia & Lymphoma|October 21, 2003
Acute myelofibrosis in a patient with diffuse large cell non Hodgkin's lymphoma and renal cancerMartin Mohren, Uwe Essbach, Astrid Franke, et al.Circulation|November 12, 2003
Effect of atrial fibrillation on hematopoietic progenitor cells: a novel pathophysiological role of the atrial natriuretic peptide?Andreas Goette, Kathleen Jentsch-Ullrich, Uwe Lendeckel, et al.Leukemia & Lymphoma|June 30, 2004
Fludarabine and bendamustine in refractory and relapsed indolent lymphoma--a multicenter phase I/II Trial of the east german society of hematology and oncology (OSHO)Michael Koenigsmann, Wolfgang Knauf, Michael Herold, et al.British Journal of Haematology|May 23, 2013
Lenalidomide, bendamustine and prednisolone exhibits a favourable safety and efficacy profile in relapsed or refractory multiple myeloma: final results of a phase 1 clinical trial OSHO - #077Wolfram Pönisch, Simone Heyn, Juliane Beck, et al.Journal of Cancer Research and Clinical Oncology|November 28, 2012
Combined bendamustine, prednisone and bortezomib (BPV) in patients with relapsed or refractory multiple myelomaWolfram Pönisch, Malvina Bourgeois, Barbara Moll, et al.Journal of Cancer Research and Clinical Oncology|August 23, 2017
Lenalidomide in combination with bendamustine and prednisolone in relapsed/refractory multiple myeloma: results of a phase 2 clinical trial (OSHO-#077)Juliane Beck, Andreas Schwarzer, Dietrich Gläser, et al.The Lancet. Oncology|January 30, 2008
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)Michael Pfreundschuh, Joerg Schubert, Marita Ziepert, et al.Pageof 2